Jade Biosciences, Inc. · NASDAQ:JBIO

Paradigm Biocapital Advisors LP reported a 5.10% stake in Jade Biosciences, Inc. (Schedule 13G)

Event Jul 10, 2026 · Filed Jul 17, 2026

Paradigm Biocapital Advisors LP reported a 5.10% stake in Jade Biosciences, Inc., 3,106,793 shares, as a passive investor on Jul 10, 2026. Filed Jul 17, 2026 (Schedule 13G).

Stake
5.10%
Shares
3,106,793
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP5.10%3,106,793
Paradigm BioCapital Advisors GP LLC5.10%3,106,793
Senai Asefaw, M.D.5.10%3,106,793
Paradigm BioCapital International Fund Ltd.4.50%2,738,259

Source

View original at SEC

Related